Analyst Consensus ?
ConsensusBuy91 ratings
Bullish8391.2%
Neutral77.7%
Bearish11.1%
1 unmapped firm rating excluded from the percentages.
Amazon.com, Inc. · AMZN · FY2026 Q2 · Calendar Q3 2026
Amazon pairs accelerating AWS growth with a heavier AI investment burden
The quarter supports a constructive operating trajectory: AWS, retail, and advertising all showed strong momentum, and management is investing heavily to capture AI demand. The evidence is balanced by substantial CapEx, margin, financing, and execution risks; the supplied analysis does not establish that future returns will offset those risks.
Reported After market closeNASDAQConsumer Cyclical
$2742.85B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$5.75
Consensus $1.82
EPS surprise
+215.9%
Reported versus consensus
Reported revenue
$200.61B
Consensus $197.03B
Revenue surprise
+1.8%
Reported versus consensus
Market reaction
event-close to next-session close
Stock move
+15.3%
Event window
SPY move
+0.7%
Same window
Abnormal move
+14.6%
Stock minus SPY
Volume
3.1×
Versus trailing sessions
Subsequent drift
-1.9%
Up to 20 sessions
AMZNSPY benchmark
Ask FN2 about AMZN FY2026 Q2
Transcript, numbers and history already loaded
Why did AMZN rise 15.3% after beating EPS estimates in FY2026 Q2?What changed in AMZN's guidance and outlook in FY2026 Q2?Give me the bull and bear case for AMZN after FY2026 Q2 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior quarter, the supplied analysis describes faster AWS growth, a higher 2026 CapEx plan of approximately $220 billion versus the prior $200 billion estimate, a larger AWS backlog, and continued expansion of AI products and delivery services. Guidance sentiment remained maintained.
Guidance delta
Management maintained Q3 guidance despite a seasonal slowdown; the supplied analysis does not identify a quantitative guidance change.
Key takeaways
- AWS growth accelerated as AI workloads and core services reinforced demand.
- Management plans approximately $220 billion of 2026 cash CapEx for data centers and server capacity, up from the prior $200 billion estimate.
- Retail and advertising remained strong, while new AI products expanded Amazon's services stack.
- The central tension is whether demand and expected data-center returns can justify the scale of investment.
Management priorities
- Expand data-center and server capacity for AI demand.
- Develop Bedrock Agents, Amazon Q, Continuum, and related AI services.
- Extend fast-delivery, grocery, Amazon Now, and supply-chain offerings.
- Evaluate broader commercialization of Trainium chips.
Follow AMZN with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$254.98Previous close
$1Low
$248.19Average
$390High
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Sep 23, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Wells Fargo | Overweight | Overweight | Maintain | Sep 3, 2026 |
| Wedbush | Outperform | Outperform | Maintain | Jul 31, 2026 |
| UBS | Buy | Buy | Maintain | Jul 31, 2026 |
| Truist Securities | Buy | Buy | Maintain | Jul 31, 2026 |
| Telsey Advisory Group | Outperform | Outperform | Maintain | Jul 31, 2026 |
| TD Cowen | Buy | Buy | Maintain | Jul 31, 2026 |
| Rosenblatt | Buy | Buy | Maintain | Jul 31, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Jul 31, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Jul 31, 2026 |
| Needham | Buy | Buy | Maintain | Jul 31, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Jul 31, 2026 |
| Keybanc | Overweight | Overweight | Maintain | Jul 31, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jul 31, 2026 |
| DA Davidson | Neutral | Neutral | Maintain | Jul 31, 2026 |
| Citizens | Market Outperform | Market Outperform | Maintain | Jul 31, 2026 |
| Citigroup | Buy | Buy | Maintain | Jul 31, 2026 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Jul 31, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Jul 31, 2026 |
| Benchmark | Buy | Buy | Maintain | Jul 31, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jul 31, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Jul 28, 2026 |
| Stifel | Buy | Buy | Maintain | May 1, 2026 |
| Susquehanna | Positive | Positive | Maintain | Apr 30, 2026 |
| Scotiabank | Sector Outperform | Sector Outperform | Maintain | Apr 30, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Apr 30, 2026 |
| Guggenheim | Buy | Buy | Maintain | Apr 30, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Apr 30, 2026 |
| Canaccord Genuity | Buy | Buy | Maintain | Apr 30, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Apr 24, 2026 |
| B of A Securities | Buy | Buy | Maintain | Apr 20, 2026 |
| Tigress Financial | Buy | Buy | Maintain | Mar 25, 2026 |
| Argus Research | Buy | Buy | Maintain | Feb 6, 2026 |
| Roth Capital | Buy | Buy | Maintain | Jan 26, 2026 |
| Jefferies | Buy | Buy | Maintain | Jan 5, 2026 |
| Rothschild & Co | Neutral | Buy | Downgrade | Nov 18, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Oct 3, 2025 |
| HSBC | Buy | Buy | Maintain | Aug 4, 2025 |
| WestPark Capital | Buy | Buy | Maintain | Aug 1, 2025 |
| JMP Securities | Market Outperform | Market Outperform | Maintain | Aug 1, 2025 |
| Baird | Outperform | Outperform | Maintain | Jul 21, 2025 |
| Raymond James | Outperform | Strong Buy | Downgrade | Apr 21, 2025 |
| Deutsche Bank | Buy | Buy | Maintain | Apr 14, 2025 |
| Citizens Capital Markets | Market Outperform | Market Outperform | Maintain | Mar 20, 2025 |
| Loop Capital | Buy | Buy | Maintain | Feb 12, 2025 |
| Maxim Group | Buy | Buy | Maintain | Feb 7, 2025 |
| Wolfe Research | Outperform | Outperform | Maintain | Jan 3, 2025 |
| Roth MKM | Buy | Buy | Maintain | Dec 9, 2024 |
| Redburn Atlantic | Buy | Buy | Maintain | Nov 26, 2024 |
| MoffettNathanson | Buy | Buy | Maintain | Nov 26, 2024 |
| Redburn Partners | Buy | Buy | Maintain | Aug 11, 2023 |
| Monness, Crespi, Hardt | Buy | Buy | Maintain | Aug 4, 2023 |
| Exane BNP Paribas | Neutral | Underperform | Upgrade | Aug 4, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Aug 4, 2023 |
| New Street Research | Buy | Buy | Maintain | May 1, 2023 |
| Cowen & Co. | Outperform | Outperform | Maintain | Feb 3, 2023 |
| MKM Partners | Buy | Buy | Maintain | Jun 6, 2022 |
| China Renaissance | Buy | Buy | Maintain | May 3, 2021 |
| Pivotal Research | Buy | Buy | Maintain | Feb 3, 2021 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Jun 26, 2020 |
| Aegis Capital | Buy | Buy | Maintain | Feb 13, 2020 |
| CFRA | Buy | Buy | Maintain | Jan 31, 2020 |
| Piper Jaffray | Overweight | Overweight | Maintain | Oct 25, 2019 |
| Bank of America | Buy | Buy | Maintain | Oct 21, 2019 |
| Societe Generale | Buy | Buy | Maintain | Apr 8, 2019 |
| Stifel Nicolaus | Buy | Buy | Maintain | Sep 27, 2018 |
| PiperJaffray | Overweight | Overweight | Maintain | Jul 27, 2018 |
| B. Riley FBR | Neutral | Buy | Downgrade | May 5, 2018 |
| Argus | Buy | Hold | Upgrade | May 5, 2018 |
| Nomura | Buy | Buy | Maintain | Feb 5, 2018 |
| Moffett Nathanson | Buy | Buy | Maintain | Dec 4, 2017 |
| Pacific Crest | Overweight | Downgrade | Apr 28, 2017 | |
| Axiom Capital | Buy | Buy | Maintain | Nov 1, 2016 |
| CLSA | Outperform | Outperform | Maintain | Jul 29, 2016 |
| William Blair | Outperform | Outperform | Maintain | Jun 10, 2016 |
| Monness Crespi Hardt | Neutral | Buy | Downgrade | Jan 4, 2016 |
| Macquarie | Outperform | Outperform | Maintain | Dec 22, 2015 |
| B. Riley Securities | Buy | Neutral | Upgrade | Jul 24, 2015 |
| B. Riley | Buy | Buy | Maintain | Jul 24, 2015 |
| Janney Montgomery Scott | Buy | Neutral | Upgrade | Apr 24, 2015 |
| Janney Capital | Buy | Neutral | Upgrade | Apr 24, 2015 |
| BGC Financial | Hold | Buy | Downgrade | Apr 21, 2015 |
| CRT Capital | Hold | Hold | Maintain | Jan 29, 2015 |
| Edward Jones | Buy | Buy | Maintain | Apr 30, 2014 |
| Argus Capital | Buy | Hold | Upgrade | Apr 16, 2014 |
| FBN Securities | Outperform | Outperform | Maintain | Jan 31, 2014 |
| Topeka Capital | Buy | Buy | Maintain | Jan 3, 2014 |
| Topeka | Buy | Buy | Maintain | Jan 3, 2014 |
| Standpoint | Sell | Sell | Maintain | Oct 28, 2013 |
| Lazard | Buy | Buy | Maintain | May 16, 2013 |
| Credit Agricole | Outperform | Buy | Maintain | Jan 30, 2013 |
| ISI Group | Buy | Buy | Maintain | Jan 25, 2013 |
| Bank oferica | Buy | Buy | Maintain | Apr 27, 2012 |
Named analyst price targets
Upside is calculated against the persisted previous close $254.98. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Analyst unavailable | $200 | $251.55 | -21.6% | Sep 17, 2026 |
| Wells Fargo | Ken Gawrelski | $338 | $254.98 | +32.6% | Sep 3, 2026 |
| Evercore ISI | Analyst unavailable | $355 | $256.26 | +39.2% | Aug 28, 2026 |
| Roth Capital | Analyst unavailable | $325 | $271.58 | +27.5% | Aug 3, 2026 |
| RBC Capital | Brad Erickson | $330 | $270.17 | +29.4% | Jul 31, 2026 |
| Deutsche Bank | Analyst unavailable | $325 | $268.16 | +27.5% | Jul 31, 2026 |
| Raymond James | Josh Beck | $390 | $268.61 | +53.0% | Jul 31, 2026 |
| Wedbush | Ygal Arounian | $310 | $270.44 | +21.6% | Jul 31, 2026 |
| KeyBanc | Justin Patterson | $350 | $235.5 | +37.3% | Jul 31, 2026 |
| Rosenblatt Securities | Barton Crockett | $345 | $235.5 | +35.3% | Jul 31, 2026 |
| Cantor Fitzgerald | Deepak Mathivanan | $320 | $235.5 | +25.5% | Jul 31, 2026 |
| Wells Fargo | Analyst unavailable | $328 | $235.5 | +28.6% | Jul 31, 2026 |
| Mizuho Securities | Lloyd Walmsley | $330 | $235.5 | +29.4% | Jul 31, 2026 |
| UBS | Stephen Ju | $318 | $235.5 | +24.7% | Jul 31, 2026 |
| Robert W. Baird | Colin Sebastian | $310 | $235.5 | +21.6% | Jul 31, 2026 |
| Telsey Advisory | Joe Feldman | $335 | $235.5 | +31.4% | Jul 31, 2026 |
| Bernstein | Mark Shmulik | $320 | $235.5 | +25.5% | Jul 31, 2026 |
| Pivotal Research | Analyst unavailable | $333 | $235.5 | +30.6% | Jul 31, 2026 |
| Piper Sandler | Thomas Champion | $320 | $235.5 | +25.5% | Jul 31, 2026 |
| Goldman Sachs | Eric Sheridan | $375 | $235.5 | +47.1% | Jul 31, 2026 |
| Morgan Stanley | Brian Nowak | $335 | $235.5 | +31.4% | Jul 31, 2026 |
| HSBC | Paul Rossington | $310 | $235.5 | +21.6% | Jul 31, 2026 |
| Wolfe Research | Shweta Khajuria | $315 | $235.5 | +23.5% | Jul 31, 2026 |
| Piper Sandler | Ross Sandler | $365 | $235.5 | +43.1% | Jul 31, 2026 |
| BMO Capital | Analyst unavailable | $360 | $229.56 | +41.2% | Jul 28, 2026 |
| Mizuho Securities | Lloyd Walmsley | $320 | $231.39 | +25.5% | Jul 28, 2026 |
| UBS | Stephen Ju | $305 | $231.39 | +19.6% | Jul 28, 2026 |
| Wells Fargo | Analyst unavailable | $322 | $249.99 | +26.3% | Jul 21, 2026 |
| KeyBanc | Analyst unavailable | $335 | $254.96 | +31.4% | Jul 16, 2026 |
| Goldman Sachs | Eric Sheridan | $335 | $241.58 | +31.4% | Jul 9, 2026 |
| Piper Sandler | Ross Sandler | $330 | $238 | +29.4% | Jun 11, 2026 |
| Truist Financial | Youssef Squali | $320 | $264.64 | +25.5% | Jun 1, 2026 |
| UBS | Analyst unavailable | $315 | $270.64 | +23.5% | Jun 1, 2026 |
| Wells Fargo | Analyst unavailable | $312 | $259.34 | +22.4% | May 20, 2026 |
| Robert W. Baird | Analyst unavailable | $300 | $268.57 | +17.7% | May 1, 2026 |
| Raymond James | Analyst unavailable | $280 | $265.06 | +9.8% | May 1, 2026 |
| Morgan Stanley | Analyst unavailable | $330 | $261.56 | +29.4% | Apr 30, 2026 |
| Scotiabank | Analyst unavailable | $325 | $258.23 | +27.5% | Apr 30, 2026 |
| Telsey Advisory | Analyst unavailable | $315 | $260.17 | +23.5% | Apr 30, 2026 |
| Needham | Analyst unavailable | $300 | $259.92 | +17.7% | Apr 30, 2026 |
| Roth Capital | Rohit Kulkarni | $300 | $259.86 | +17.7% | Apr 30, 2026 |
| RBC Capital | Analyst unavailable | $320 | $259.76 | +25.5% | Apr 30, 2026 |
| Deutsche Bank | Analyst unavailable | $315 | $260 | +23.5% | Apr 30, 2026 |
| Goldman Sachs | Analyst unavailable | $325 | $260.71 | +27.5% | Apr 30, 2026 |
| Oppenheimer | Analyst unavailable | $320 | $260.78 | +25.5% | Apr 30, 2026 |
| Bernstein | Mark Shmulik | $315 | $263.04 | +23.5% | Apr 30, 2026 |
| Cantor Fitzgerald | Deepak Mathivanan | $330 | $263.04 | +29.4% | Apr 30, 2026 |
| Susquehanna | Analyst unavailable | $325 | $263.04 | +27.5% | Apr 30, 2026 |
| UBS | Stephen Ju | $333 | $263.04 | +30.6% | Apr 30, 2026 |
| Piper Sandler | Thomas Champion | $315 | $263.04 | +23.5% | Apr 30, 2026 |
| Guggenheim | Simeon Siegel | $320 | $263.04 | +25.5% | Apr 30, 2026 |
| Wells Fargo | Analyst unavailable | $313 | $263.04 | +22.8% | Apr 30, 2026 |
| Stifel Nicolaus | Analyst unavailable | $319 | $263.04 | +25.1% | Apr 30, 2026 |
| Wolfe Research | Analyst unavailable | $320 | $263.04 | +25.5% | Apr 30, 2026 |
| Barclays | Analyst unavailable | $330 | $263.04 | +29.4% | Apr 30, 2026 |
| Pivotal Research | Analyst unavailable | $320 | $263.04 | +25.5% | Apr 30, 2026 |
| Mizuho Securities | Analyst unavailable | $325 | $261.12 | +27.5% | Apr 28, 2026 |
| Oppenheimer | Analyst unavailable | $275 | $255.08 | +7.9% | Apr 24, 2026 |
| BMO Capital | Analyst unavailable | $315 | $255.36 | +23.5% | Apr 23, 2026 |
| KeyBanc | Analyst unavailable | $325 | $250.56 | +27.5% | Apr 20, 2026 |
| Truist Financial | Analyst unavailable | $285 | $254.43 | +11.8% | Apr 17, 2026 |
| Wells Fargo | Analyst unavailable | $304 | $210.11 | +19.2% | Feb 23, 2026 |
| Truist Financial | Analyst unavailable | $280 | $204.99 | +9.8% | Feb 6, 2026 |
| Wedbush | Analyst unavailable | $300 | $204.78 | +17.7% | Feb 6, 2026 |
| Scotiabank | Nat Schindler | $275 | $202.21 | +7.9% | Feb 6, 2026 |
| BMO Capital | Analyst unavailable | $310 | $222.69 | +21.6% | Feb 6, 2026 |
| Oppenheimer | Analyst unavailable | $260 | $222.69 | +2.0% | Feb 6, 2026 |
| UBS | Analyst unavailable | $301 | $222.69 | +18.0% | Feb 6, 2026 |
| Evercore ISI | Analyst unavailable | $285 | $222.69 | +11.8% | Feb 6, 2026 |
| Piper Sandler | Thomas Champion | $260 | $222.69 | +2.0% | Feb 6, 2026 |
| KeyBanc | Justin Patterson | $285 | $222.69 | +11.8% | Feb 6, 2026 |
| Morgan Stanley | Brian Nowak | $300 | $222.69 | +17.7% | Feb 6, 2026 |
| D.A. Davidson | Analyst unavailable | $175 | $222.69 | -31.4% | Feb 6, 2026 |
| Cantor Fitzgerald | Deepak Mathivanan | $250 | $222.69 | -2.0% | Feb 6, 2026 |
| UBS | Analyst unavailable | $304 | $237.47 | +19.2% | Feb 3, 2026 |
| UBS | Analyst unavailable | $311 | $242.96 | +22.0% | Feb 3, 2026 |
| Oppenheimer | Jason Helfstein | $315 | $244.68 | +23.5% | Jan 28, 2026 |
| KeyBanc | Justin Patterson | $308 | $244.68 | +20.8% | Jan 28, 2026 |
| Stifel Nicolaus | Mark Kelley | $300 | $238.42 | +17.7% | Jan 27, 2026 |
| Roth Capital | Rohit Kulkarni | $295 | $239.16 | +15.7% | Jan 26, 2026 |
| Redburn Partners | Analyst unavailable | $230 | $232.01 | -9.8% | Jan 21, 2026 |
| Raymond James | Analyst unavailable | $260 | $236.65 | +2.0% | Jan 15, 2026 |
| Wells Fargo | Analyst unavailable | $301 | $247.34 | +18.0% | Jan 12, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $260 | $241.56 | +2.0% | Jan 8, 2026 |
| Wolfe Research | Shweta Khajuria | $275 | $233.06 | +7.9% | Jan 5, 2026 |
| Jefferies | Brent Thill | $300 | $226.5 | +17.7% | Jan 5, 2026 |
| BMO Capital | Analyst unavailable | $304 | $222.09 | +19.2% | Dec 16, 2025 |
| Guggenheim | Analyst unavailable | $300 | $227.92 | +17.7% | Dec 9, 2025 |
| UBS | Analyst unavailable | $300 | $230.2 | +17.7% | Dec 5, 2025 |
| Wells Fargo | Ken Gawrelski | $295 | $233.88 | +15.7% | Dec 2, 2025 |
| Oppenheimer | Analyst unavailable | $305 | $233.18 | +19.6% | Dec 1, 2025 |
| Mizuho Securities | Lloyd Walmsley | $315 | $254 | +23.5% | Nov 4, 2025 |
| Wedbush | Analyst unavailable | $340 | $254.92 | +33.3% | Nov 3, 2025 |
| Seaport Global | Analyst unavailable | $290 | $245.56 | +13.7% | Oct 31, 2025 |
| RBC Capital | Brad Erickson | $300 | $246.57 | +17.7% | Oct 31, 2025 |
| KeyBanc | Analyst unavailable | $303 | $222.86 | +18.8% | Oct 31, 2025 |
| UBS | Stephen Ju | $310 | $246.18 | +21.6% | Oct 31, 2025 |
| Susquehanna | Shyam Patil | $300 | $222.86 | +17.7% | Oct 31, 2025 |
| Cantor Fitzgerald | Analyst unavailable | $315 | $222.86 | +23.5% | Oct 31, 2025 |
| Evercore ISI | Analyst unavailable | $335 | $248.62 | +31.4% | Oct 31, 2025 |
| D.A. Davidson | Analyst unavailable | $300 | $248.62 | +17.7% | Oct 31, 2025 |
| Robert W. Baird | Colin Sebastian | $285 | $248.62 | +11.8% | Oct 31, 2025 |
| Stifel Nicolaus | Mark Kelly | $295 | $245.81 | +15.7% | Oct 31, 2025 |
| Oppenheimer | Jason Helfstein | $290 | $222.86 | +13.7% | Oct 31, 2025 |
| Roth Capital | Analyst unavailable | $270 | $222.86 | +5.9% | Oct 31, 2025 |
| Bernstein | Analyst unavailable | $300 | $248.62 | +17.7% | Oct 31, 2025 |
| Truist Financial | Youssef Squali | $290 | $245.92 | +13.7% | Oct 31, 2025 |
| Raymond James | Josh Beck | $275 | $222.86 | +7.9% | Oct 31, 2025 |
| Canaccord Genuity | Analyst unavailable | $300 | $222.86 | +17.7% | Oct 31, 2025 |
| JMP Securities | Analyst unavailable | $300 | $222.86 | +17.7% | Oct 31, 2025 |
| Morgan Stanley | Brian Nowak | $315 | $222.86 | +23.5% | Oct 31, 2025 |
| Piper Sandler | Ross Sandler | $300 | $222.86 | +17.7% | Oct 31, 2025 |
| Telsey Advisory | Joe Feldman | $300 | $222.86 | +17.7% | Oct 31, 2025 |
| BMO Capital | Analyst unavailable | $300 | $222.86 | +17.7% | Oct 31, 2025 |
| UBS | Analyst unavailable | $279 | $227.53 | +9.4% | Oct 28, 2025 |
| KeyBanc | Analyst unavailable | $300 | $221.09 | +17.7% | Oct 23, 2025 |
| Mizuho Securities | Analyst unavailable | $300 | $222.17 | +17.7% | Sep 29, 2025 |
| Needham | Laura Martin | $265 | $214.75 | +3.9% | Aug 1, 2025 |
| Piper Sandler | Thomas Champion | $250 | $225.02 | -2.0% | Jul 11, 2025 |
| Roth Capital | Rohit Kulkarni | $250 | $221.91 | -2.0% | Jul 8, 2025 |
| Truist Financial | Analyst unavailable | $250 | $219.92 | -2.0% | Jul 2, 2025 |
| Bernstein | Analyst unavailable | $235 | $220.46 | -7.8% | Jul 1, 2025 |
| JMP Securities | Nicholas Jones | $250 | $189.98 | -2.0% | May 2, 2025 |
| Telsey Advisory | Joseph Feldman | $235 | $180.6 | -7.8% | Apr 23, 2025 |
| JMP Securities | Analyst unavailable | $285 | $201.36 | +11.8% | Mar 27, 2025 |
| Cantor Fitzgerald | Deepak Mathivanan | $270 | $222.11 | +5.9% | Jan 7, 2025 |
| Bernstein | Mark Shmulik | $265 | $231.15 | +3.9% | Dec 18, 2024 |
| Piper Sandler | Tom Champion | $225 | $206.17 | -11.8% | Nov 27, 2024 |
| Maxim Group | Tom Forte | $260 | $197.93 | +2.0% | Nov 1, 2024 |
| Seaport Global | Aaron Kessler | $225 | $197.93 | -11.8% | Nov 1, 2024 |
| Piper Sandler | Ross Sandler | $235 | $197.93 | -7.8% | Nov 1, 2024 |
| RBC Capital | Brad Erickson | $225 | $197.93 | -11.8% | Nov 1, 2024 |
| Goldman Sachs | Eric Sheridan | $240 | $197.93 | -5.9% | Nov 1, 2024 |
| JMP Securities | Nicholas Jones | $265 | $192.73 | +3.9% | Oct 31, 2024 |
| Wolfe Research | Shweta Khajuria | $250 | $189.3 | -2.0% | Oct 28, 2024 |
| Pivotal Research | Jeffrey Wlodarczak | $260 | $189.03 | +2.0% | Oct 11, 2024 |
| Scotiabank | Nat Schindler | $245 | $186.65 | -3.9% | Oct 10, 2024 |
| Cantor Fitzgerald | Deepak Mathivanan | $210 | $182.72 | -17.6% | Oct 9, 2024 |
| Morgan Stanley | Brian Nowak | $210 | $182.34 | -17.6% | Oct 3, 2024 |
| Truist Financial | Youssef Squali | $265 | $187.97 | +3.9% | Sep 30, 2024 |
| Bernstein | Mark Shmulik | $210 | $193.88 | -17.6% | Sep 24, 2024 |
| Evercore ISI | Mark Mahaney | $240 | $189.87 | -5.9% | Sep 19, 2024 |
| Cantor Fitzgerald | Deepak Mathivanan | $230 | $176.67 | -9.8% | Sep 5, 2024 |
| Wells Fargo | Ken Gawrelski | $225 | $177.04 | -11.8% | Aug 26, 2024 |
| Wedbush | Scott Devitt | $225 | $166.6 | -11.8% | Aug 2, 2024 |
| JMP Securities | Nicholas Jones | $225 | $186.31 | -11.8% | Jul 31, 2024 |
| Goldman Sachs | Eric Sheridan | $250 | $181.71 | -2.0% | Jul 30, 2024 |
| UBS | Stephen Ju | $224 | $183.2 | -12.1% | Jul 30, 2024 |
| Bank of America Securities | Justin Post | $220 | $182.5 | -13.7% | Jul 26, 2024 |
| Needham | Laura Martin | $210 | $187.93 | -17.6% | Jul 17, 2024 |
| Wolfe Research | Daniel Kurnos | $200 | $193.02 | -21.6% | Jul 16, 2024 |
| Barclays | Ross Sandler | $220 | $192.72 | -13.7% | Jul 16, 2024 |
| Summit Redstone Partners | Doug Anmuth | $240 | $195.56 | -5.9% | Jul 11, 2024 |
| MKM Partners | Rohit Kulkarni | $210 | $199.66 | -17.6% | Jul 9, 2024 |
| Wells Fargo | Ken Gawrelski | $239 | $197.85 | -6.3% | Jun 28, 2024 |
| Robert W. Baird | Colin Sebastian | $213 | $186.1 | -16.5% | Jun 21, 2024 |
| Needham | Quinn Bolton | $95 | $174.78 | -62.7% | May 31, 2024 |
| Tigress Financial | Ivan Feinseth | $245 | $179.32 | -3.9% | May 30, 2024 |
| MoffettNathanson | Michael Morton | $246 | $182.8 | -3.5% | May 23, 2024 |
| Oppenheimer | Jason Helfstein | $220 | $185.18 | -13.7% | May 15, 2024 |
| Loop Capital Markets | Rob Sanderson | $225 | $186.24 | -11.8% | May 6, 2024 |
| Loop Capital Markets | Rob Sanderson | $215 | $175 | -15.7% | May 1, 2024 |
| Roth Capital | Rohit Kulkarni | $210 | $175 | -17.6% | May 1, 2024 |
| Stifel Nicolaus | Mark Kelley | $228 | $175 | -10.6% | May 1, 2024 |
| Morgan Stanley | Brian Nowak | $220 | $175 | -13.7% | May 1, 2024 |
| Evercore ISI | Mark Mahaney | $225 | $175 | -11.8% | May 1, 2024 |
| Raymond James | Josh Beck | $205 | $175 | -19.6% | May 1, 2024 |
| Mizuho Securities | James Lee | $240 | $175 | -5.9% | May 1, 2024 |
| UBS | Stephen Ju | $215 | $176.59 | -15.7% | Apr 25, 2024 |
| Maxim Group | Tom Forte | $218 | $183.32 | -14.5% | Apr 17, 2024 |
| Truist Financial | Youssef Squali | $216 | $183.32 | -15.3% | Apr 17, 2024 |
| Roth Capital | Rohit Kulkarni | $205 | $182.33 | -19.6% | Apr 16, 2024 |
| Stifel Nicolaus | Mark Kelley | $224 | $183.62 | -12.1% | Apr 16, 2024 |
| Robert W. Baird | Colin Sebastian | $205 | $186.13 | -19.6% | Apr 15, 2024 |
| Jefferies | Brent Thill | $225 | $189.05 | -11.8% | Apr 11, 2024 |
| D.A. Davidson | Gil Luria | $235 | $184.42 | -7.8% | Apr 10, 2024 |
| Piper Sandler | Tom Champion | $205 | $185.19 | -19.6% | Apr 9, 2024 |
| Mizuho Securities | James Lee | $230 | $180 | -9.8% | Apr 4, 2024 |
| Wells Fargo | Ken Gawrelski | $217 | $180.38 | -14.9% | Apr 1, 2024 |
| Truist Financial | Youssef Squali | $195 | $179.08 | -23.5% | Mar 22, 2024 |
| Goldman Sachs | Toshiya Hari | $84 | $175.39 | -67.1% | Mar 8, 2024 |
| Needham | Laura Martin | $205 | $171.96 | -19.6% | Feb 2, 2024 |
| Mizuho Securities | James Lee | $220 | $151 | -13.7% | Jan 17, 2024 |
| Telsey Advisory | Joseph Feldman | $185 | $153.95 | -27.4% | Dec 28, 2023 |
| Oppenheimer | Jason Helfstein | $200 | $146.52 | -21.6% | Dec 1, 2023 |
| Needham | Alex Henderson | $245 | $147.73 | -3.9% | Nov 28, 2023 |
| Oppenheimer | Jason Helfstein | $170 | $129.75 | -33.3% | Oct 27, 2023 |
| Seaport Global | Aaron Kessler | $145 | $128.16 | -43.1% | Oct 24, 2023 |
| JMP Securities | Nicholas Jones | $175 | $132.9 | -31.4% | Oct 16, 2023 |
| D.A. Davidson | Tom Forte | $150 | $127.22 | -41.2% | Sep 26, 2023 |
| Wedbush | Michael Pachter | $180 | $140.89 | -29.4% | Sep 15, 2023 |
| Mizuho Securities | James Lee | $180 | $138.23 | -29.4% | Sep 8, 2023 |
| Needham | Laura Martin | $195 | $137.99 | -23.5% | Sep 7, 2023 |
| Telsey Advisory | Joseph Feldman | $160 | $128.91 | -37.2% | Aug 4, 2023 |
| J.P. Morgan | Doug Anmuth | $145 | $139.57 | -43.1% | Aug 3, 2023 |
| Truist Financial | Youssef Squali | $144 | $130 | -43.5% | Jul 21, 2023 |
| Loop Capital Markets | Rob Sanderson | $180 | $129.17 | -29.4% | Jun 22, 2023 |
| Wells Fargo | Ken Gawrelski | $159 | $124.55 | -37.6% | Jun 8, 2023 |
| J.P. Morgan | Doug Anmuth | $135 | $100.31 | -47.1% | Mar 16, 2023 |
| Rosenblatt Securities | Barton Crockett | $103 | $83.12 | -59.6% | Jan 6, 2023 |
| UBS | Lloyd Walmsley | $125 | $85.14 | -51.0% | Jan 5, 2023 |
| New Street | Barton Crockett | $103 | $98.49 | -59.6% | Nov 15, 2022 |
| Telsey Advisory | Joseph Feldman | $97.78 | $110.96 | -61.7% | Oct 28, 2022 |
| Jefferies | Brent Thill | $135 | $103.41 | -47.1% | Oct 28, 2022 |
| Mizuho Securities | James Lee | $135 | $110.96 | -47.1% | Oct 28, 2022 |
| Monness | Brian White | $136 | $103.41 | -46.7% | Oct 28, 2022 |
| Wedbush | Michael Pachter | $140 | $103.41 | -45.1% | Oct 28, 2022 |
| Atlantic Equities | James Cordwell | $120 | $103.41 | -52.9% | Oct 28, 2022 |
| Robert W. Baird | Colin Sebastian | $130 | $110.96 | -49.0% | Oct 28, 2022 |
| Wedbush | Michael Pachter | $140 | $103.41 | -45.1% | Oct 28, 2022 |
| Piper Sandler | Thomas Champion | $125 | $110.96 | -51.0% | Oct 28, 2022 |
| Piper Sandler | Thomas Champion | $125 | $103.41 | -51.0% | Oct 28, 2022 |
| Morgan Stanley | Brian Nowak | $140 | $110.96 | -45.1% | Oct 28, 2022 |
| Cowen & Co. | John Blackledge | $150 | $103.41 | -41.2% | Oct 28, 2022 |
| Needham | Laura Martin | $120 | $103.41 | -52.9% | Oct 28, 2022 |
| Benchmark Co. | Daniel Kurnos | $125 | $103.41 | -51.0% | Oct 28, 2022 |
| JMP Securities | Nicholas Jones CFA | $140 | $103.41 | -45.1% | Oct 28, 2022 |
| Cowen & Co. | John Blackledge | $150 | $110.96 | -41.2% | Oct 28, 2022 |
| Bernstein | Mark Shmulik | $125 | $103.41 | -51.0% | Oct 28, 2022 |
| Morgan Stanley | Brian Nowak | $140 | $103.41 | -45.1% | Oct 28, 2022 |
| RBC Capital | Brad Erickson | $135 | $110.96 | -47.1% | Oct 27, 2022 |
| Goldman Sachs | Eric Sheridan | $175 | $110.96 | -31.4% | Oct 27, 2022 |
| Morgan Stanley | Erik Woodring | $180 | $119.82 | -29.4% | Oct 25, 2022 |
| Mizuho Securities | James Lee | $155 | $114.84 | -39.2% | Oct 19, 2022 |
| Truist Financial | Analyst unavailable | $170 | $116.17 | -33.3% | Sep 28, 2022 |
| D.A. Davidson | Tom Forte | $151 | $138.23 | -40.8% | Aug 22, 2022 |
| UBS | Analyst unavailable | $180 | $135.53 | -29.4% | Jul 29, 2022 |
| Cowen & Co. | Analyst unavailable | $215 | $135.53 | -15.7% | Jul 29, 2022 |
| Jefferies | Analyst unavailable | $165 | $135.47 | -35.3% | Jul 29, 2022 |
| Canaccord Genuity | Analyst unavailable | $200 | $135.45 | -21.6% | Jul 29, 2022 |
| Citigroup | Analyst unavailable | $185 | $136.91 | -27.4% | Jul 29, 2022 |
| Deutsche Bank | Analyst unavailable | $175 | $136.64 | -31.4% | Jul 29, 2022 |
| J.P. Morgan | Analyst unavailable | $185 | $122.28 | -27.4% | Jul 29, 2022 |
| Barclays | Analyst unavailable | $200 | $122.28 | -21.6% | Jul 29, 2022 |
| JMP Securities | Analyst unavailable | $180 | $122.28 | -29.4% | Jul 29, 2022 |
| Wolfe Research | Analyst unavailable | $170 | $122.28 | -33.3% | Jul 29, 2022 |
| Raymond James | Analyst unavailable | $164 | $122.28 | -35.7% | Jul 29, 2022 |
| Piper Sandler | Analyst unavailable | $175 | $122.28 | -31.4% | Jul 29, 2022 |
| Telsey Advisory | Analyst unavailable | $150 | $122.28 | -41.2% | Jul 29, 2022 |
| Stifel Nicolaus | Scott Devitt | $200 | $122.28 | -21.6% | Jul 29, 2022 |
| Needham | Laura Martin | $175 | $122.28 | -31.4% | Jul 29, 2022 |
| Mizuho Securities | James Lee | $155 | $122.28 | -39.2% | Jul 29, 2022 |
| Rosenblatt Securities | Barton Crockett | $118 | $122.28 | -53.7% | Jul 29, 2022 |
| Wells Fargo | Robert Coolbrith | $200 | $122.28 | -21.6% | Jul 29, 2022 |
| Piper Sandler | Thomas Champion | $175 | $122.28 | -31.4% | Jul 29, 2022 |
| Stifel Nicolaus | Scott Devitt | $185 | $118.38 | -27.4% | Jul 27, 2022 |
| Credit Suisse | Phil Winslow | $1 | $0.29 | -99.6% | Jul 26, 2022 |
| Credit Suisse | Stephen Ju | $190 | $117.73 | -25.5% | Jul 26, 2022 |
| Credit Suisse | Analyst unavailable | $170 | $121.14 | -33.3% | Jul 26, 2022 |
| Oppenheimer | Analyst unavailable | $160 | $122.42 | -37.2% | Jul 25, 2022 |
| Deutsche Bank | Analyst unavailable | $155 | $122.74 | -39.2% | Jul 21, 2022 |
| Jefferies | Analyst unavailable | $150 | $121.99 | -41.2% | Jul 20, 2022 |
| Monness | Brian White | $172 | $110.63 | -32.5% | Jul 15, 2022 |
| Citigroup | Analyst unavailable | $180 | $108.94 | -29.4% | Jul 14, 2022 |
| Telsey Advisory | Analyst unavailable | $145 | $109.22 | -43.1% | Jul 13, 2022 |
| UBS | Kunal Madhukar | $167 | $115.54 | -34.5% | Jul 11, 2022 |
| Redburn Partners | Alex Haissl | $135 | $54.8 | -47.1% | Jul 4, 2022 |
| Evercore ISI | Mark Mahaney | $180 | $107.37 | -29.4% | Jun 30, 2022 |
| Tigress Financial | Ivan Feinseth | $116 | $54.5 | -54.5% | Jun 29, 2022 |
| J.P. Morgan | Analyst unavailable | $175 | $109.94 | -31.4% | Jun 29, 2022 |
| Wolfe Research | Analyst unavailable | $140 | $107.4 | -45.1% | Jun 29, 2022 |
| Rosenblatt Securities | Barton Crockett | $107 | $102.95 | -58.0% | Jun 14, 2022 |
| Stifel Nicolaus | Scott Devitt | $152 | $87.72 | -40.4% | Jun 13, 2022 |
| MKM Partners | Rohit Kulkarni | $180 | $109.65 | -29.4% | Jun 11, 2022 |
| Goldman Sachs | Analyst unavailable | $170 | $116.15 | -33.3% | Jun 10, 2022 |
| Loop Capital Markets | Daniel Salmon | $172.5 | $121.18 | -32.3% | Jun 8, 2022 |
| Morgan Stanley | Brian Nowak | $175 | $128.14 | -31.4% | Jun 6, 2022 |
| MKM Partners | Rohit Kulkarni | $180 | $124.79 | -29.4% | Jun 6, 2022 |
| Bank of America Securities | Justin Post | $188 | $124.79 | -26.3% | Jun 6, 2022 |
| JMP Securities | Analyst unavailable | $172.5 | $120.21 | -32.3% | Jun 1, 2022 |
| Morgan Stanley | Analyst unavailable | $175 | $120.21 | -31.4% | Jun 1, 2022 |
| Jefferies | Analyst unavailable | $162.5 | $115.15 | -36.3% | May 31, 2022 |
| Loop Capital Markets | Analyst unavailable | $141.25 | $113.6 | -44.6% | May 27, 2022 |
| Credit Suisse | Stephen Ju | $185 | $107.59 | -27.4% | May 21, 2022 |
| Deutsche Bank | Lee Horowitz | $175 | $124.28 | -31.4% | May 2, 2022 |
| Evercore ISI | Mark Mahaney | $205 | $124.28 | -19.6% | May 1, 2022 |
| Raymond James | Aaron Kessler | $165 | $124.28 | -35.3% | Apr 29, 2022 |
| MKM Partners | Analyst unavailable | $181.25 | $126.51 | -28.9% | Apr 29, 2022 |
| Truist Financial | Analyst unavailable | $175 | $126.54 | -31.4% | Apr 29, 2022 |
| Canaccord Genuity | Analyst unavailable | $187.5 | $128.39 | -26.5% | Apr 29, 2022 |
| RBC Capital | Analyst unavailable | $175 | $144.6 | -31.4% | Apr 29, 2022 |
| UBS | Analyst unavailable | $209.25 | $144.6 | -17.9% | Apr 29, 2022 |
| JMP Securities | Analyst unavailable | $180 | $144.6 | -29.4% | Apr 29, 2022 |
| Morgan Stanley | Brian Nowak | $190 | $144.6 | -25.5% | Apr 29, 2022 |
| Needham | Analyst unavailable | $175 | $144.6 | -31.4% | Apr 29, 2022 |
| Telsey Advisory | Analyst unavailable | $170 | $144.6 | -33.3% | Apr 29, 2022 |
| BMO Capital | Daniel Salmon | $172.5 | $124.28 | -32.3% | Apr 29, 2022 |
| Susquehanna | Shyam Patil | $190 | $124.28 | -25.5% | Apr 29, 2022 |
| Morgan Stanley | Brian Nowak | $190 | $144.6 | -25.5% | Apr 29, 2022 |
| Mizuho Securities | James Lee | $197.5 | $124.28 | -22.5% | Apr 29, 2022 |
| MKM Partners | Rohit Kulkarni | $181.25 | $124.28 | -28.9% | Apr 29, 2022 |
| Telsey Advisory | Joe Feldman | $170 | $124.28 | -33.3% | Apr 29, 2022 |
| Citigroup | Jason Bazinet | $205 | $124.28 | -19.6% | Apr 29, 2022 |
| Stifel Nicolaus | Scott Devitt | $190 | $144.6 | -25.5% | Apr 29, 2022 |
| Piper Sandler | Thomas Champion | $170 | $124.28 | -33.3% | Apr 29, 2022 |
| Robert W. Baird | Colin Sebastian | $187.5 | $144.6 | -26.5% | Apr 29, 2022 |
| Wedbush | Michael Pachter | $175 | $124.28 | -31.4% | Apr 29, 2022 |
| Monness | Brian White | $185 | $124.28 | -27.4% | Apr 29, 2022 |
| Jefferies | Brent Thill | $185 | $124.28 | -27.4% | Apr 29, 2022 |
| Deutsche Bank | Lee Horowitz | $175 | $124.28 | -31.4% | Apr 29, 2022 |
| Cowen & Co. | John Blackledge | $212.5 | $124.28 | -16.7% | Apr 29, 2022 |
| Benchmark Co. | Daniel Kurnos | $185 | $144.6 | -27.4% | Apr 29, 2022 |
| Wolfe Research | Deepak Mathivanan | $185 | $124.28 | -27.4% | Apr 29, 2022 |
| Needham | Laura Martin | $175 | $124.28 | -31.4% | Apr 29, 2022 |
| RBC Capital | Brad Erickson | $175 | $144.6 | -31.4% | Apr 29, 2022 |
| Wells Fargo | Brian Fitzgerald | $200 | $124.28 | -21.6% | Apr 29, 2022 |
| RBC Capital | Brad Erickson | $175 | $124.28 | -31.4% | Apr 29, 2022 |
| JMP Securities | Andrew Boone | $180 | $124.28 | -29.4% | Apr 29, 2022 |
| Rosenblatt Securities | Barton Crockett | $145 | $124.28 | -43.1% | Apr 29, 2022 |
| Barclays | Ross Sandler | $212 | $124.28 | -16.9% | Apr 29, 2022 |
| UBS | Lloyd Walmsley | $227.5 | $144.35 | -10.8% | Apr 25, 2022 |
| Cowen & Co. | Analyst unavailable | $220 | $154.08 | -13.7% | Apr 20, 2022 |
| Citigroup | Analyst unavailable | $205 | $155 | -19.6% | Apr 20, 2022 |
| Evercore ISI | Analyst unavailable | $158.12 | $154.56 | -38.0% | Apr 20, 2022 |
| Rosenblatt Securities | Analyst unavailable | $150 | $157.14 | -41.2% | Apr 19, 2022 |
| Wolfe Research | Deepak Mathivanan | $210 | $145.52 | -17.6% | Mar 12, 2022 |
| Tigress Financial | Ivan Feinseth | $232.75 | $152.6 | -8.7% | Feb 19, 2022 |
| Bank of America Securities | Justin Post | $222.5 | $153.29 | -12.7% | Feb 12, 2022 |
| Citigroup | Jason Bazinet | $205.75 | $161.19 | -19.3% | Feb 9, 2022 |
| Needham | Laura Martin | $207.5 | $157.64 | -18.6% | Feb 4, 2022 |
| KeyBanc | Edward Yruma | $200 | $157.64 | -21.6% | Feb 4, 2022 |
| Guggenheim | Seth Sigman | $215 | $157.64 | -15.7% | Feb 4, 2022 |
| Wedbush | Michael Pachter | $197.5 | $157.64 | -22.5% | Feb 4, 2022 |
| Jefferies | Brent Thill | $200 | $157.64 | -21.6% | Feb 4, 2022 |
| Goldman Sachs | Eric Sheridan | $210 | $157.64 | -17.6% | Feb 4, 2022 |
| BMO Capital | Daniel Salmon | $180 | $157.64 | -29.4% | Feb 4, 2022 |
| MKM Partners | Rohit Kulkarni | $205 | $157.64 | -19.6% | Feb 4, 2022 |
| Susquehanna | Shyam Patil | $250 | $157.64 | -2.0% | Feb 4, 2022 |
| Mizuho Securities | James Lee | $197.5 | $157.64 | -22.5% | Feb 4, 2022 |
| Canaccord Genuity | Michael Graham | $214.95 | $157.64 | -15.7% | Feb 4, 2022 |
| J.P. Morgan | Doug Anmuth | $225 | $157.64 | -11.8% | Feb 4, 2022 |
| JMP Securities | Ronald Josey | $200 | $157.64 | -21.6% | Feb 4, 2022 |
| Barclays | Ross Sandler | $220 | $157.64 | -13.7% | Feb 4, 2022 |
| Credit Suisse | Stephen Ju | $205 | $157.64 | -19.6% | Feb 4, 2022 |
| UBS | Lloyd Walmsley | $231.25 | $157.64 | -9.3% | Feb 4, 2022 |
| Monness | Brian White | $225 | $157.64 | -11.8% | Feb 4, 2022 |
| Stifel Nicolaus | Scott Devitt | $220 | $138.85 | -13.7% | Feb 3, 2022 |
| Robert W. Baird | Colin Sebastian | $200 | $138.85 | -21.6% | Feb 3, 2022 |
| Goldman Sachs | Eric Sheridan | $205 | $143.98 | -19.6% | Jan 29, 2022 |
| Morgan Stanley | Brian Nowak | $210 | $162.14 | -17.6% | Jan 16, 2022 |
| Cowen & Co. | John Blackledge | $225 | $169.57 | -11.8% | Dec 13, 2021 |
| Benchmark Co. | Daniel Kurnos | $200 | $168.62 | -21.6% | Oct 29, 2021 |
| Truist Financial | Youssef Squali | $200 | $168.62 | -21.6% | Oct 29, 2021 |
| Oppenheimer | Jason Helfstein | $210 | $168.62 | -17.6% | Oct 29, 2021 |
| Loop Capital Markets | Anthony Chukumba | $188.75 | $167.74 | -26.0% | Aug 4, 2021 |
| Bernstein | Mark Shmulik | $210 | $179.26 | -17.6% | Jul 21, 2021 |
| Argus Research | Jim Kelleher | $200 | $185.97 | -21.6% | Jul 9, 2021 |
| China Renaissance Securities (US) Inc. | Ella Ji | $225 | $169.32 | -11.8% | May 3, 2021 |
Track every rating change on AMZN the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationAmazon.com, Inc. operates a vast global retail enterprise, distributing consumer goods and subscription services through both its extensive online platforms and a network of physical stores across North America and internationally. Its operations are structured into three primary segments: North America, International, and Amazon Web Services (AWS). The company's product offerings encompass both merchandise and content procured for direct resale, alongside items sold by third-party merchants on its platform. Furthermore, the company develops and markets its own range of electronic devices, such as Kindle e-readers, Fire tablets and TVs, Ring, Blink, eero, and Echo products. It also invests in the development and production of original media content.…
Historical context
All AMZN earningsConsumer Cyclical peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| AZO AutoZone, Inc. | FY2026 Q4 · Calendar Q3 2026 | +3.6% | +3.3% | AutoZone pairs commercial momentum with an aggressive FY2027 expansion plan |
| LEN-B Lennar Corporation | FY2026 Q3 · Calendar Q3 2026 | — | — | Lennar: Efficiency Gains Offset Housing-Market Pressures |
| LEN Lennar Corporation | FY2026 Q3 · Calendar Q3 2026 | — | -4.1% | Lennar Holds Volume Guidance as Margins Improve Despite Housing Headwinds |
| TCOM Trip.com Group Limited | FY2026 Q2 · Calendar Q3 2026 | +22.3% | +3.0% | Trip.com pairs international growth with heavier AI investment |
| CASY Casey's General Stores, Inc. | FY2027 Q1 · Calendar Q3 2026 | +8.7% | -14.2% | Casey's Q1: Prepared Food Drives Growth as Fuel Margins Stay Volatile |
| LULU Lululemon Athletica Inc. | FY2026 Q2 · Calendar Q3 2026 | +63.1% | -17.4% | Lululemon lowers FY2026 outlook as North America weakens |
Latest beats and misses
Who reports nextBeat on EPS
- AZOFY2026 Q4 · September 22, 2026+3.6% EPS+3.3% move
- FPSFY2026 Q4 · September 15, 2026+4.3% EPS+9.5% move
- TCOMFY2026 Q2 · September 15, 2026+22.3% EPS+3.0% move
- KRFY2026 Q2 · September 11, 2026+2.8% EPS+2.7% move
- ADBEFY2026 Q3 · September 10, 2026+0.8% EPS+1.4% move
- ORCLFY2027 Q1 · September 10, 2026+10.3% EPS-1.7% move
Get the AMZN recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-07-31T00:08:10.512240+00:00
- FN2 earnings calendar · 2026-09-04T01:23:15.205020+00:00
- Polygon adjusted daily market bars · 2026-09-23T08:40:51.275637+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-23T08:40:51.272819+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-09-23. For educational purposes only; not investment advice.